Supreme Court: Benefit of Section 436A CrPC Extends Even to Accused Under PMLA  ||  Supreme Court: Can’t Order Confiscation of Vehicle Without Hearing its Registered Owner  ||  Allahabad High Court: Taunting a Person for Giving Less Dowry Not a Penal Offence  ||  All. HC: Collector Being Quasi-Judicial Authority Has No Statutory Power to Review/Recall Order  ||  All HC: High Court Appointing Arbitrator has Power to Extend Arbitrator's Mandate u/s 29A of A&C Act  ||  SC: Centre Recommended to Frame Comprehensive Sentencing Policy  ||  Supreme Court: Court Which Granted Bail Can Cancel it if Serious Allegations Made  ||  Supreme Court: SEZ Developers Must Apply for Recognition and be Scrutinized  ||  SC: Comments to be Made Within Public View to Punish Person for Casteist Insults Under SC/ ST Act  ||  P&H HC: Bail Petition Rejected of Travel Agent Accused of Defrauding a Man for Processing Visa    

Allergan, Intas Pharma Settle Trademark Dispute over Usage of Trademarks Botox and BTX-A - (05 Oct 2015)

US-based Allergan Inc and Gujarat-based Intas Pharmaceuticals have entered into settlement over usage of trademarks Botox and BTX-A. Intas Pharma acknowledged Allergan's exclusive right for registered marks Botox and BTX-A, while the US-based firm accepted Intas' use of the mark BTXA without hyphen.


Share :        

Disclaimer | Copyright 2024 - All Rights Reserved